African swine fever is an economically important swine disease caused by a large virus (ASFV) containing a long DNA genome of 170-190 kbp (for reviews see Vinuela, 1987; Costa, 1990) . ASFV has similarities in genome structure and replication strategy to the poxviruses but is morphologically different and is classified separately. The complete nucleotide sequence of a non-virulent tissue culture adapted isolate (Ba71V) (Yanez et al., 1995) and more than 90 kbp from a virulent isolate (Malawi LIL20/1) have been determined (Dixon et al., 1994; Yozawa et al., 1994) . The genome encodes more than 150 open reading frames (ORFs). Virions have a complex structure consisting of a nucleoprotein core surrounded by an internal lipid membrane and an icosahedral virus capsid. Extracellular virions have an additional lipid membrane (Carrascosa et al., 1984) . Virion morphogenesis takes place in perinuclear factory areas. Genes encoding a number of structural proteins have been identified, including the major capsid protein p72 (LopezOtin et al., 1990) , pl0 (Munoz et al., 1993) , pll'5 (Alcami et al., 1993) and several proteins which are derived by proteolytic cleavage from a 220 kDa precursor (Simon-Mateo et al., 1993) . A number of other virion proteins, pl 7 (Simon-Mateo et al., 1995) , p12 (Alcami et al., 1992) , p54 or jl3L (Rodriguez et al., 1994; Sun et al., 1995) , contain putative transmembrane regions and are probably incorporated into virion lipid membranes. Of * Author for correspondence. Fax +44 1483 232448. e-mail Linda.Dixon@BBSRC.AC.UK these, the putative virus attachment protein, p 12, is in the external envelope (Carrascosa et al., 1993) . A number of enzymes are also packaged into virions for use early during the next round of infection (Salas et al., 1981) .
Pigs which survive ASFV infection are generally resistant to challenge with homologous but not heterologous virus strains. However, the mechanism(s) by which immune protection is mediated is poorly understood (see Vinuela, 1987) . Identification of proteins involved in the immune response to the virus remains one of the most important tasks in ASFV research. Proteins which contain putative transmembrane regions are of particular interest since they may be incorporated into either the internal or external virion membranes and/or be expressed on the surface of infected cells. Here we report the identification of an ASF virion protein which is encoded by ORF jl8L on the Malawi LIL20/1 isolate genome (E199L on the Ba71V genome) and contains a hydrophobic domain near the C terminus.
ORF j 18L is 20 kbp from the right end of the Malawi (LIL20/1) isolate genome, is read towards the left DNA terminus and encodes a protein of 195 amino acids with a predicted molecular mass of 21.7 kDa (Dixon et al., 1994) . Database searches did not reveal significant identity to other published protein sequences. The sequence is relatively cysteine rich and contains a total of 11 cysteines spaced throughout the first 140 amino acids. DNA encoding the N-terminal 153 amino acids of the jl8L protein was amplified by PCR from clone LMwl8 (Dixon, 1988 ) (forward primer, 5' CGCGGATCCAT-GTCATGCATGCCAATTTCGACG; reverse primer, 5' GCGCCCGGGTTACATCACATTAATTAAAAA-CGT), and cloned downstream of the glutathione S-transferase (GST) gene in the expression vector pGEX-2T (Pharmacia) using BamHI and SmaI sites incorporated into the primers. A protein of 41.0 kDa was detected in the IPTG-induced cell lysates, but not in uninduced cultures nor in cells transformed with the pGEX-2T vector without insert. The molecular mass of the expressed protein was about 3 kDa smaller than the predicted size.
The expressed fusion protein was purified by affinity chromatography on glutathione-Sepharose columns and coated onto ELISA plates. These were incubated with normal pig serum, and antisera from pigs which had recovered from infection with different ASFV isolates (Malta, Belgium, Uganda and one pig infected with multiple strains). The expressed j 18L-GST fusion protein but not the GST protein alone was recognized by the antisera from infected but not from uninfected pigs (data not shown). This indicates that the jl8L protein is expressed during ASFV infection and antibodies against jl8L are induced in infected pigs.
To obtain sufficient protein for antibody production, insoluble expressed GST-j 18L fusion protein was separated by SDS-PAGE and purified by electroelution. The purified protein was used to immunize rabbits and mice to make polyclonal antiserum and monoclonal antibodies specific for the jl8L gene product. Monoclonal antibodies were screened by ELISA against extracts from E. coli expressing both GST alone or GST-jl8L fusion protein and those which reacted with only the fusion protein selected. Both the monoclonal and polyclonal antibodies reacted on Western blots with the GST-j 18L fusion protein (data not shown).
A recombinant vaccinia virus (VV), VVjl8L, containing the complete jl8L ORF from the Malawi (LIL20/1) isolate downstream from the VV p7.5 promoter and within the thymidine kinase gene of VV WR strain was constructed. Cells were infected with either wild-type VV WR strain, recombinant VVjl8L or the tissue culture-adapted ASFV strain Uganda. Cell extracts were prepared at 24 h post-infection and separated by SDS-PAGE followed by immunoblotting using either the monoclonal or polyclonal antibodies against the E. coli expressed jl8L protein. A protein of 19.0 kDa was detected in extracts of the VVjl8L infected cells and of 20.0 kDa in extracts of Uganda ASFV-infected cells, but neither protein was detected in extracts of the mock infected or wild-type VV WR-infected cells. These proteins were not detected by normal rabbit serum or hybridoma cell medium (data not shown). These experiments demonstrated that both polyclonal and monoclonal antibodies were specific for the j 18L gene product, which was expressed as a protein with relative molecular mass of 19.0 or 20.0 kDa. The difference in size between the protein detected in VVjl8L infected cells and in ASFV infected cells may reflect differences in size of the ORF in the Malawi and Uganda ASFV isolates. Alternatively, it may reflect differences due to expression of the protein in a heterologous vector. The molecular mass of the protein detected was about 1 kDa less than that predicted.
To investigate the temporal control of jl8L protein expression during ASFV infection, cells were infected with the tissue culture-adapted Uganda ASFV strain and harvested at different times post-infection. Cell extracts were separated by SDS-PAGE and the j 18L protein was detected by Western blotting using the monoclonal antibody against the jl8L protein (j18L-14). As Fig.1 (a) shows, the 20"0 kDa protein was detected from 10 h postinfection, suggesting that j 18L protein is expressed late during ASFV infection. To confirm this, cells were infected with the tissue culture-adapted Uganda ASFV strain in the absence or presence of cytosine arabinoside, which inhibits viral DNA replication and late gene expression. Cell extracts were separated by SDS-PAGE and the jl8L protein was detected as described above. Expression of the j 18L protein was inhibited by including 50 gg/ml cytosine arabinoside in the culture medium (Fig. 1 b) , confirming that jl8L is a late protein.
The jl8L protein sequence has two potential Asn glycosylation sites. However, growth of ASFV in the presence of 10 gg/ml tunicamycin or 13 pM-monensin did not affect the mobility of the j 18L protein, suggesting that it is not modified by N-or O-linked glycosylation. Although we have not investigated whether the jl8L protein is modified by phosphorylation or myristoylation, it does not correspond in size to previously identified major phosphorylated or myristoylated proteins incorporated into virions (Salas et al., 1988; Aguado et al., 1991) .
Pig bone marrow cells were infected with eight ASFV isolates from different locations in Europe (Lisbon 57, Tomera 83) and Africa (Malawi LIL20/1, Tanzania, Mozambique, Burundi, Republic of South Africa or Uganda). Cell extracts were separated by SDS-PAGE and the j 18L protein was detected by Western blotting using rabbit antisera against the jl8L protein. The sequence of the jl8L homologue encoded by ORF E199L on the Ba71V ASFV isolate genome (Yanez et al., 1995) is closely conserved in length (199 compared to 195 amino acids) and has 89% identical amino acids compared with the jl8L encoded protein.
Virus was purified from the extracellular medium of IBRS2 cells infected with Uganda isolate and virion proteins were analysed by SDS-PAGE and Western blotting (Carrascosa et al., 1984) . Silver staining showed that virion proteins had a typical pattern for ASFV (Fig.  2c) . The jl8L protein was detected by immunoblotting using the rabbit antiserum (Fig. 2a) and monoclonal antibody (j 18L-14) (Fig. 2 b) specific for the j 18L protein.
Two proteins with relative molecular masses of 15.0 and 20"0 kDa were detected by the rabbit antiserum but not by the preimmune serum (Fig. 2a) . The 20.0 kDa protein was the same size as the protein detected in infected cells. The 15"0 kDa protein could be a cleaved product of the 20.0 kDa protein or a cross-reactive protein. The failure to detect this 15.0 kDa protein in infected cells may be because it is present at much lower concentrations in extracts of infected cells than in purified virions. Interestingly, only the 20.0 kDa protein was detected in purified extracellular virions by the monoclonal antibody j 18L-14 (Fig. 2b) indicating that this antibody is specific for an epitope present in the 20.0 kDa protein only. The proteins detected by immunoblotting did not co-migrate with any major bands detected by silver staining (Fig.  2 c) , suggesting that the j 18L protein is a relatively minor component of virions.
To exclude possible non-specific association of the j 18L protein with purified virions, sequential extraction of virions with different concentrations of the non-ionic detergent n-octylglucoside (NOG) was carried out at 4 °C for 1 h. The extracted virion proteins were separated from the treated virus using a Centricon 100 concentrator (Amicon), separated by SDS-PAGE and either detected by silver staining (Fig. 2 c) or transferred to nitrocellulose membranes followed by immunoblotting using the j 18L-specific monoclonal antibody j 18L-14 (see Fig. 2 b) . The number of solubilized virion proteins detected by silver staining increased in parallel with increasing NOG concentration. Thus, treatment of virions with 0.1% NOG released five major proteins which ranged in molecular mass from 30 to 46 kDa. Small amounts of several more proteins were solubilized by 0.25 % NOG, including a protein of molecular mass 72 kDa which is probably the major capsid protein. Most major virion proteins were solubilized by treatment with 0"5 % NOG. These observations indicated that treatment of the virus sequentially with an incremental concentration range of NOG resulted, as expected, in the sequential liberation of virion proteins. The j 18L protein was detected in proteins extracted from virions with 0.5-5 % NOG (Fig. 2 b) , but was not among those proteins first extracted from virions by lower concentrations of NOG. This demonstrates that the jl8L protein is incorporated into extracellular ASF virions and is not present as an unincorporated adsorbed contaminant. The results also suggest that the j l8L protein is not in the external virion envelope as it is not solubilized by low concentrations of NOG, although immunogold electron microscopy is required to confirm this.
To localize the jl8L protein in infected cells, IBRS2 cells were infected with the Uganda tissue cultureadapted ASFV strain and harvested at 5, 16 or 24 h postinfection. Infected cells were fixed and permeabilized with cold methanol and then stained with monoclonal antibody against j 18L protein (j 18L-14) followed by goat anti-mouse IgG-FITC conjugate. The j 18L protein was detected, by immunofluorescence, from 10 h post-infection and was localized mainly in intensely stained perinuclear areas (Fig. 3 ). These were probably virus factory areas which were also detected by staining with a monoclonal antibody (4H3, a gift from T. Whittal, IAH, Pirbright, UK) which recognizes a major 72 kDa virion protein and stains virus factories (Fig. 3) .
Our results demonstrate that the jl8L protein is incorporated into ASFV particles. The j 18L protein has a hydrophobic region near the C terminus which may be inserted into membranes post-translationally in a similar manner to the C-terminal hydrophobic domains of synaptobrevin-like proteins (Kutay et al., 1995) . Unlike the synaptobrevin-like proteins, which have their hydrophobic domain at the C terminus, in thej 18L protein the hydrophobic domain is 24 amino acids from the C terminus. However, addition of an extra 13 amino acids downstream of the hydrophobic C-terminal region of synaptobrevin does not interfere with post-translational membrane insertion of synaptobrevin (Kutay et al., 1995) . It is therefore possible that the C-terminal hydrophobic domain ofj 18L may function to anchor it in the membrane. Ifj 18L is inserted into virion membranes it may have an important role in virion morphogenesis. A vaccinia virus membrane protein which is present in intracellular mature virions also has a C-terminal membrane anchor. These proteins may be involved in interactions involved in docking together of different layers of the virion or in packaging of the nucleoprotein core (Niles & Seto, 1988) .
